186 related articles for article (PubMed ID: 10230676)
1. Molecular genetics of prostate cancer.
Visakorpi T
Ann Chir Gynaecol; 1999; 88(1):11-6. PubMed ID: 10230676
[TBL] [Abstract][Full Text] [Related]
2. Molecular cytogenetics of prostate cancer.
Nupponen NN; Visakorpi T
Microsc Res Tech; 2000 Dec; 51(5):456-63. PubMed ID: 11074616
[TBL] [Abstract][Full Text] [Related]
3. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization.
Visakorpi T; Kallioniemi AH; Syvänen AC; Hyytinen ER; Karhu R; Tammela T; Isola JJ; Kallioniemi OP
Cancer Res; 1995 Jan; 55(2):342-7. PubMed ID: 7529134
[TBL] [Abstract][Full Text] [Related]
4. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.
Strohmeyer DM; Berger AP; Moore DH; Bartsch G; Klocker H; Carroll PR; Loening SA; Jensen RH
Prostate; 2004 Apr; 59(1):43-58. PubMed ID: 14991865
[TBL] [Abstract][Full Text] [Related]
5. Chromosomal aberrations in prostate cancer xenografts detected by comparative genomic hybridization.
Laitinen S; Karhu R; Sawyers CL; Vessella RL; Visakorpi T
Genes Chromosomes Cancer; 2002 Sep; 35(1):66-73. PubMed ID: 12203791
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor gene alterations and chromosomal gains and losses in prostate carcinomas appearing during finasteride treatment for benign prostatic hyperplasia.
Koivisto PA; Schleutker J; Helin H; Ehren-van Eekelen C; Kallioniemi OP; Trapman J
Clin Cancer Res; 1999 Nov; 5(11):3578-82. PubMed ID: 10589774
[TBL] [Abstract][Full Text] [Related]
7. Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancer.
El Gammal AT; Brüchmann M; Zustin J; Isbarn H; Hellwinkel OJ; Köllermann J; Sauter G; Simon R; Wilczak W; Schwarz J; Bokemeyer C; Brümmendorf TH; Izbicki JR; Yekebas E; Fisch M; Huland H; Graefen M; Schlomm T
Clin Cancer Res; 2010 Jan; 16(1):56-64. PubMed ID: 20028754
[TBL] [Abstract][Full Text] [Related]
8. [Genetics of prostate cancer].
Thomas F; Jaïs P; Cohen-Akenine A
Bull Cancer; 2001 Mar; 88(3):287-94. PubMed ID: 11313206
[TBL] [Abstract][Full Text] [Related]
9. DNA sequence copy number aberrations in prostate cancers: a comparison of comparative genomic hybridization data between Japan and European countries.
Matsuda K; Matsuyama H; Hara T; Yoshihiro S; Oga A; Kawauchi S; Furuya T; Izumi H; Naito K; Sasaki K
Cancer Genet Cytogenet; 2004 Jul; 152(2):119-23. PubMed ID: 15262429
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of proximal 6q deletions in prostate cancer.
Cooney KA; Wetzel JC; Consolino CM; Wojno KJ
Cancer Res; 1996 Sep; 56(18):4150-3. PubMed ID: 8797584
[TBL] [Abstract][Full Text] [Related]
11. [Molecular pathology of prostate carcinoma. Academic playground or guide for diagnosis and therapy planning?].
Bubendorf L
Verh Dtsch Ges Pathol; 2004; 88():158-64. PubMed ID: 16892547
[TBL] [Abstract][Full Text] [Related]
12. Molecular biology of progression of prostate cancer.
Nupponen N; Visakorpi T
Eur Urol; 1999; 35(5-6):351-4. PubMed ID: 10325488
[TBL] [Abstract][Full Text] [Related]
13. 5q11, 8p11, and 10q22 are recurrent chromosomal breakpoints in prostate cancer cell lines.
Pan Y; Lui WO; Nupponen N; Larsson C; Isola J; Visakorpi T; Bergerheim US; Kytölä S
Genes Chromosomes Cancer; 2001 Feb; 30(2):187-95. PubMed ID: 11135436
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal changes during development and progression of prostate adenocarcinomas.
Zitzelsberger H; Engert D; Walch A; Kulka U; Aubele M; Höfler H; Bauchinger M; Werner M
Br J Cancer; 2001 Jan; 84(2):202-8. PubMed ID: 11161378
[TBL] [Abstract][Full Text] [Related]
15. Statistical dissection of genetic pathways involved in prostate carcinogenesis.
Ribeiro FR; Diep CB; Jerónimo C; Henrique R; Lopes C; Eknaes M; Lingjaerde OC; Lothe RA; Teixeira MR
Genes Chromosomes Cancer; 2006 Feb; 45(2):154-63. PubMed ID: 16235241
[TBL] [Abstract][Full Text] [Related]
16. Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray.
Jiang M; Li M; Fu X; Huang Y; Qian H; Sun R; Mao Y; Xie Y; Li Y
Prostate; 2008 Oct; 68(14):1496-509. PubMed ID: 18366025
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetics of prostate cancer. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
Debruyne FM; Collins VP; van Dekken H; Jenkins RB; Klocker H; Schalken JA; Sesterhenn IA
Scand J Urol Nephrol Suppl; 1994; 162():65-71; discussion 115-27. PubMed ID: 7817161
[TBL] [Abstract][Full Text] [Related]
18. Chromosomal aberrations in prostate cancer.
Saramaki O; Visakorpi T
Front Biosci; 2007 May; 12():3287-301. PubMed ID: 17485299
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal basis of adenocarcinoma of the prostate.
Verma RS; Manikal M; Conte RA; Godec CJ
Cancer Invest; 1999; 17(6):441-7. PubMed ID: 10434955
[TBL] [Abstract][Full Text] [Related]
20. Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma.
Schulz WA; Elo JP; Florl AR; Pennanen S; Santourlidis S; Engers R; Buchardt M; Seifert HH; Visakorpi T
Genes Chromosomes Cancer; 2002 Sep; 35(1):58-65. PubMed ID: 12203790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]